[go: up one dir, main page]

MX2021008089A - Composiciones y metodos para modular el crecimiento del cabello. - Google Patents

Composiciones y metodos para modular el crecimiento del cabello.

Info

Publication number
MX2021008089A
MX2021008089A MX2021008089A MX2021008089A MX2021008089A MX 2021008089 A MX2021008089 A MX 2021008089A MX 2021008089 A MX2021008089 A MX 2021008089A MX 2021008089 A MX2021008089 A MX 2021008089A MX 2021008089 A MX2021008089 A MX 2021008089A
Authority
MX
Mexico
Prior art keywords
hair growth
methods
compositions
modulating hair
modulating
Prior art date
Application number
MX2021008089A
Other languages
English (en)
Inventor
Michael E Jung
William E Lowry
Xiaoguang Liu
Heather R Christofk
Aimee Flores
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX2021008089A publication Critical patent/MX2021008089A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente divulgación se refiere a compuestos que tienen la capacidad de inhibir el portador de piruvato en la mitocondria y promover el crecimiento del cabello; la divulgación se refiere además a métodos para promover el crecimiento del cabello o tratar afecciones o trastornos que afecten el crecimiento del cabello, como la calvicie o la alopecia.
MX2021008089A 2019-01-02 2019-12-30 Composiciones y metodos para modular el crecimiento del cabello. MX2021008089A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962787609P 2019-01-02 2019-01-02
PCT/US2019/068905 WO2020142413A1 (en) 2019-01-02 2019-12-30 Compositions and methods for modulating hair growth

Publications (1)

Publication Number Publication Date
MX2021008089A true MX2021008089A (es) 2021-08-05

Family

ID=71406935

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021008089A MX2021008089A (es) 2019-01-02 2019-12-30 Composiciones y metodos para modular el crecimiento del cabello.

Country Status (13)

Country Link
US (1) US20220048908A1 (es)
EP (1) EP3906240A4 (es)
JP (1) JP2022516136A (es)
KR (1) KR20210110817A (es)
CN (1) CN113631555A (es)
AR (1) AR117555A1 (es)
AU (1) AU2019418584A1 (es)
BR (1) BR112021012829A2 (es)
CA (1) CA3124820A1 (es)
IL (1) IL284397B2 (es)
MX (1) MX2021008089A (es)
SG (1) SG11202106471RA (es)
WO (1) WO2020142413A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019015552A2 (pt) 2017-02-24 2020-03-17 The Regents Of The University Of California Composições e métodos para promover crescimento capilar com os inibidores de mpc1
AU2018294351B2 (en) 2017-06-30 2022-12-22 The Regents Of The University Of California Compositions and methods for modulating hair growth
WO2022006040A1 (en) * 2020-06-30 2022-01-06 The Regents Of The University Of California Compositions and methods for modulating hair growth
WO2022006039A1 (en) * 2020-06-30 2022-01-06 The Regents Of The University Of California Compositions and methods for modulating hair growth
KR20230028924A (ko) 2021-08-23 2023-03-03 현대모비스 주식회사 차량용 램프 및 그 램프를 포함하는 차량
EP4457226A1 (en) * 2021-12-29 2024-11-06 Pelage Pharmaceuticals, Inc. Compounds for treatment of hair loss
US20250145626A1 (en) * 2021-12-29 2025-05-08 Pelage Pharmaceuticals, Inc. Compounds for treatment of hair loss
CN114949055A (zh) * 2022-02-10 2022-08-30 上海希尔维生物科技有限公司 栀子提取物和氧代戊二酸组合物及在防脱育发领域的应用
CN117164479A (zh) * 2023-08-21 2023-12-05 甘肃康巴斯生物科技有限公司 一种氨基乙腈盐酸盐的制备方法
CN121005682A (zh) * 2024-05-24 2025-11-25 上海医药工业研究院有限公司 一种2-苯基-吡咯类化合物、其制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412719D0 (en) * 1994-06-24 1994-08-17 Erba Carlo Spa Substituted azaindolylidene compounds and process for their preparation
CA2936551A1 (en) * 2014-01-24 2015-07-30 Confluence Life Sciences, Inc. Substituted pyrrolopyridines and pyrrolopyrazines for treating cancer or inflammatory diseases
WO2018039612A1 (en) * 2016-08-26 2018-03-01 The Regents Of The University Of California Compositions and methods for promoting hair growth with mpc1 inhibitors
AU2018294351B2 (en) * 2017-06-30 2022-12-22 The Regents Of The University Of California Compositions and methods for modulating hair growth

Also Published As

Publication number Publication date
EP3906240A1 (en) 2021-11-10
AU2019418584A1 (en) 2021-07-08
CN113631555A (zh) 2021-11-09
BR112021012829A2 (pt) 2021-11-09
IL284397B1 (en) 2025-07-01
CA3124820A1 (en) 2020-07-09
SG11202106471RA (en) 2021-07-29
JP2022516136A (ja) 2022-02-24
US20220048908A1 (en) 2022-02-17
IL284397B2 (en) 2025-11-01
IL284397A (en) 2021-08-31
KR20210110817A (ko) 2021-09-09
EP3906240A4 (en) 2022-10-05
AR117555A1 (es) 2021-08-11
WO2020142413A1 (en) 2020-07-09

Similar Documents

Publication Publication Date Title
MX2021008089A (es) Composiciones y metodos para modular el crecimiento del cabello.
CL2019003886A1 (es) Composiciones y métodos para modular el crecimiento del cabello.
CL2019001709A1 (es) Derivados pirazol como inhibidores de malt1.
CL2019001878A1 (es) Compuestos de microarn y métodos de modulación de la actividad de mir-21 (divisional solicitud 201402844).
MX2019002750A (es) Derivados de pirazolopiridina como moduladores de cinasa 1 progenitora hematopoyetica (hpk1) y usos de los mismos para tratamiento de cancer.
CO2019011543A2 (es) Inhibidores de pd-1/pd-l1
MX2018014032A (es) Composiciones de pirrolopirrol como activadores de piruvato cinasa (pkr).
CO2018003168A2 (es) Moduladores de la expresión de kras
BR112017024547A2 (pt) tratamento de recrescimento de cabelo e estimulante de crescimento
EA201692076A1 (ru) Новые ингибиторы нитрификации
MX349593B (es) Composicion farmaceutica o cosmetica para el tratamiento de alopecia.
CL2021000650A1 (es) Moduladores de la expresión de pnpla3
MX2021002215A (es) Derivados de tetrahidropiridopirimidina como moduladores de ahr.
CO2022000481A2 (es) Inhibidores de enzimas
CL2019002340A1 (es) Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc1.
BR112022000229A2 (pt) Composição para uso no tratamento da perda de cabelo
BR112016001919A2 (pt) composição cosmética e processo de tratamento cosmético
CL2020000676A1 (es) Composiciones y métodos para modular el crecimiento del cabello.
ECSP21003171A (es) Dinucleótidos cíclicos como agonistas de sting
BR112015016206A2 (pt) moduladores de ship1 e métodos relacionados com os mesmos
MX2022000781A (es) Triterpenoides sintéticos heteroaromáticos sustituidos polarmente en c17, y métodos de uso de los mismos.
MX2016006351A (es) Inhibidores de tirosina cinasa de bruton.
MX2018000538A (es) Composicion antimicrobiana.
MX2020003554A (es) Moduladores de la expresion de enac.
AR116655A1 (es) Composiciones y métodos para modular el crecimiento del cabello